Invistics the leading provider of advanced inventory visibility and analytics software, today announced significant product updates for its Flowlytics drug diversion detection solution. One notable feature is the creation of a detection highlighting clinicians with the Highest Evidence of Activity to Investigate (HEAT)™, which helps uncover potential diversions quickly. This upgrade also includes alerts to detect if infusions or Patient-Controlled Analgesia (PCA) have been diverted.
Also Read: Treating Patients Beyond Borders – Antengene Successfully Hosted Its First R&D Day
Invistics’ drug diversion software was funded by a grant from the National Institutes of Health (NIH) and has a true positive accuracy rate of over 90 percent, so nine out of 10 events that the software flags as drug diversion are true instances of missing drugs or dangerous practice issues. The use of machine learning software to integrate data from multiple complex IT systems to detect drug diversion across the leaky supply chain is a key component to effectively managing this issue at a time when 64% of healthcare professionals report lacking confidence in diversion prevention.
“Drug diversion prevention and monitoring are a core safety issue,” said Terri Vidals, B.S. Pharm, Drug Diversion Specialist and Lead Pharmacist Consultant at Rxpert Solutions. “Machine learning software, like Invistics’ cloud-based solution, give facilities an advantage in detecting and stopping this costly problem. All drug diversion programs should incorporate prevention and education, early identification, appropriate intervention, and re-integration, when possible.”
The update will give Flowlytics’ users individualized options for data tracking and offers visualization improvements to improve user experience and data security. New features to Invistics’ software include:
A new and enhanced user dashboard that streamlines visualization of data allowing users to have a more holistic view of their drug diversion prevention and detection program. Invistics also added an investigation dashboard which displays all risky transactions for a single clinician in one comprehensive location.
Administrators can now create targeted watch groups to track new employees or workers who are exhibiting concerning behaviors indicative of drug diversion.